Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden

Poorly differentiated pancreatic neuroendocrine carcinomas (NECs) are rare and aggressive malignancies with rapid disease progression and early widespread metastasis. Given histology similarity, they are commonly treated with platinum-based chemotherapy as small cell lung cancer (SCLC). However, no...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Nai-Wen, Tan, Kien-Thiam, Li, Chien-Feng, Kuo, Yu-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628778/
https://www.ncbi.nlm.nih.gov/pubmed/34898561
http://dx.doi.org/10.3390/curroncol28060388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628778/
https://www.ncbi.nlm.nih.gov/pubmed/34898561
http://dx.doi.org/10.3390/curroncol28060388

Ejemplares similares